Thank you so much for sharing all of that DM! The similar companies I’ve held stock in that haven’t quite made it all have something in common - they couldn’t get their target market to pay attention. We clearly have their attention, we just need to bob around in the ocean of corporate governance while they get the pieces in place. It might still never fully happen the way we hope, but I’m very willing to take the bet that it will with the way things are lining up.
Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-24
Add to My Watchlist
What is My Watchlist?
